Try our mobile app

General information

Country: UNITED STATES

Sector: Diagnostics and Research

Danaher Corporation designs, manufactures, and markets professional, medical, industrial and commercial products, and services in the sectors of test and measurement, environmental, life sciences, dental, and industrial technologies.
Website: danaher.com


  • Bad financial results growth rate -2.5% (average between last period year over year growth for revenue and EBITDA), there is acceleration compared to average historical growth rates (-3.1%)
  • Dividend yield for the last twelve months 0.6%
  • Free cash flow yield -1.5% (LTM)
  • Share price is 7.4% higher than minimum and 38.0% lower than maximum for the last 3 years
  • The company is undervalued by EV / LTM EBITDA multiple compared to target level (27.2x vs
    )
  • Fundamental value created in LTM (estimate)
  • For the last 3 months insiders sold company shares on $249.0 mln (-0.174% of cap.)

Key Financials (Download financials)

Ticker: DHR
Share price, USD:  (+0.4%)187.48
year average price 237.35  


year start price 261.40 2024-05-23

max close price 280.76 2024-08-01

min close price 174.64 2025-04-08

current price 187.61 2025-05-22
Common stocks: 727 076 992

Dividend Yield:  0.6%
FCF Yield LTM: -1.5%
EV / LTM EBITDA: 27.2x
EV / EBITDA annualized: 25.9x
Last revenue growth (y/y):  -0.9%
Last growth of EBITDA (y/y):  -4.0%
Historical revenue growth:  +0.9%
Historical growth of EBITDA:  -7.1%
Target EV / EBITDA (hist percentile):
Fundamental value created in LTM:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 136 312
Net Debt ($m): 14 492
EV (Enterprise Value): 150 804
EBITDA LTM ($m): 5 548
EV / LTM EBITDA: 27.2x
Price to Book: 2.6x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2025-05-22zacks.com

Why Is Danaher (DHR) Down 4.8% Since Last Earnings Report?

2025-05-22zacks.com

Here's Why Investors Should Consider Retaining Danaher Stock Now

2025-05-15seekingalpha.com

Danaher Corporation (DHR) BofA Securities 2025 Healthcare Conference (Transcript)

2025-05-09zacks.com

CVS vs. DHR: Which Stock Is the Better Value Option?

2025-05-07prnewswire.com

Danaher to Present at Bank of America Securities Healthcare Conference

2025-05-06prnewswire.com

Danaher Announces Quarterly Dividend

2025-05-06seekingalpha.com

Danaher: A Capital Intensive Business Offering Low Risk, Low Reward Opportunity

2025-05-02seekingalpha.com

Danaher: Q1 Beat Fails To Trigger Guidance Upgrade

2025-04-22zacks.com

Danaher Q1 Earnings Beat Estimates, Life Sciences Sales Down Y/Y

2025-04-22seekingalpha.com

Danaher Corporation (DHR) Q1 2025 Earnings Call Transcript
More information for subscribed users:
detailed calculation of
Potential and Created Value,
website traffic data